"Peptides: The Science, Uses & Safety." Huberman Lab podcast, June 1, 2026
Weekly e-cigarette use similarly fell from 30% to 16% of respondents
Broader utility drives market dominance: GLP1s address not only diabetes and obesity, but also cardiovascular and other metabolic comorbidities, creating opportunities to position them as multicondition solutions
Taken together, preclinical and clinical studies have demonstrated that GLP-1 receptor agonists exert pleiotropic effects extending beyond glycemic control, influencing multiple organ systems including the nervous, respiratory, hepatic, renal, cardiovascular, reproductive, and immune systems (Figure 4)
GLP-1 is involved in a complex neuro-hormonal network regulating food intake
La variabilidad gentica puede jugar un papel en la respuesta al tratamiento, aunque actualmente no existen pruebas farmacogenmicas validadas para predecir la respuesta a estos medicamentos en la prctica clnica